Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Impact of Covid-19 Lockdown on Stroke Admissions and Treatments in Campania.
Candelaresi P, Manzo V, Servillo G, Muto M, Barone P, Napoletano R, Saponiero R, Andreone V, Palma V, Spitaleri D, D'Onofrio F, Maniscalco G, Salvatore S, Leone G, Capone E, Schettino C, Romano D, Martusciello G, Miniello S, Mazzaferro MP, Ascione S. Candelaresi P, et al. Among authors: maniscalco g. J Stroke Cerebrovasc Dis. 2021 Jan;30(1):105448. doi: 10.1016/j.jstrokecerebrovasdis.2020.105448. Epub 2020 Nov 4. J Stroke Cerebrovasc Dis. 2021. PMID: 33166767 Free PMC article.
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region.
de Waure C, Di Nardo F, Mazzucco W, Nedovic D, Battaglia MA, Busillo V, Di Iorio W, Gallo A, Lanzillo R, Lombardi E, Maniscalco GT, Orefice G, Petracca M, Romano F, Sinisi L, Spadera AP, Spitaleri D, Vivo P, Ricciardi W. de Waure C, et al. Among authors: maniscalco gt. Neurol Sci. 2016 Feb;37(2):315-22. doi: 10.1007/s10072-015-2389-5. Epub 2015 Oct 6. Neurol Sci. 2016. PMID: 26439919
GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis.
Maniscalco GT, Mariotto S, Höftberger R, Capra R, Servillo G, Manzo V, Napolitano M, Candelaresi P, Gerevini S, Ferrari S, Bozzetti S, Spatola M, Florio C. Maniscalco GT, et al. Neurology. 2020 Sep 1;95(9):399-401. doi: 10.1212/WNL.0000000000010310. Epub 2020 Jul 10. Neurology. 2020. PMID: 32651290 No abstract available.
One year experience with erenumab: real-life data in 30 consecutive patients.
Ranieri A, Alfieri G, Napolitano M, Servillo G, Candelaresi P, Di Iorio W, Longo K, Maniscalco GT, Renna R, Rippa M, Salvatore S, Sagnelli A, Florio C, Manzo V. Ranieri A, et al. Among authors: maniscalco gt. Neurol Sci. 2020 Dec;41(Suppl 2):505-506. doi: 10.1007/s10072-020-04677-y. Neurol Sci. 2020. PMID: 32845486 No abstract available.
Anti-MOG-associated demyelinating disorders: two sides of the same coin.
Maniscalco GT, Allegorico L, Alfieri G, Napolitano M, Ranieri A, Renna R, Servillo G, Pezzella M, Capone E, Altomare L, Spiniello M, Ferrari S, Manzo V, Mariotto S. Maniscalco GT, et al. Neurol Sci. 2021 Apr;42(4):1531-1534. doi: 10.1007/s10072-020-04892-7. Epub 2020 Nov 14. Neurol Sci. 2021. PMID: 33190197
Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project.
Maniscalco GT, Brescia Morra V, Florio C, Lus G, Tedeschi G, Cianfrani M, Docimo R, Miniello S, Romano F, Sinisi L, Spitaleri DLA, Longo G, Trama U, Triassi M, Fasm Group, Scavone C, Capuano A. Maniscalco GT, et al. Pharmaceuticals (Basel). 2020 Dec 15;13(12):466. doi: 10.3390/ph13120466. Pharmaceuticals (Basel). 2020. PMID: 33333889 Free PMC article.
134 results